Last updated: November 27, 2024
Sponsor: Shandong University
Overall Status: Completed
Phase
N/A
Condition
Precancerous Condition
Treatment
The diagnosis of Artificial Intelligence and endosopists
Clinical Study ID
NCT05464108
2022SDU-QILU-111
Ages 40-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients aged 40-75 years who undergo the IEE examination
Exclusion
Exclusion Criteria:
patients with severe cardiac, cerebral, pulmonary or renal dysfunction orpsychiatric
disorders who cannot participate in gastroscopy
patients with previous surgical procedures on the stomach
patients with contraindications to biopsy
patients who refuse to sign the informed consent form
Study Design
Total Participants: 1080
Treatment Group(s): 1
Primary Treatment: The diagnosis of Artificial Intelligence and endosopists
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
December 30, 2023
Study Description
Connect with a study center
Department of Gastrology, QiLu Hospital, Shandong University
Jinan, Shandong 250012
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.